江中药业2025半年度拟派3.17亿元红包

Summary of Key Points Core Viewpoint - Jiangzhong Pharmaceutical announced a semi-annual distribution plan for 2025, proposing a cash dividend of 5 yuan per 10 shares, totaling 317 million yuan, which represents 60.78% of its net profit for the period. The dividend yield is calculated at 2.22% based on the average trading price for the period [2]. Distribution History - The company has a history of dividend distributions since its listing, with the latest proposal marking the 30th distribution. The cash distribution amounts and dividend yields have varied over the years, with notable distributions including: - 2024.12.31: 10派7元, 444 million yuan, 3.04% yield - 2023.12.31: 10派7元, 441 million yuan, 3.48% yield - 2022.12.31: 10派6.5元, 409 million yuan, 4.51% yield [1][2]. Financial Performance - For the first half of 2025, Jiangzhong Pharmaceutical reported operating revenue of 2.141 billion yuan, a year-on-year decrease of 5.79%. However, net profit increased by 5.80% to 522 million yuan, with basic earnings per share at 0.82 yuan [3]. Market Activity - The stock experienced a net outflow of 2.931 million yuan in principal funds on the day of the announcement, with a total net outflow of 27.178 million yuan over the past five days [4]. - The latest margin financing balance for the stock is 244 million yuan, reflecting a decrease of 4.394 million yuan over the past five days, a decline of 1.77% [5]. Industry Comparison - In the pharmaceutical and biotechnology sector, Jiangzhong Pharmaceutical's cash distribution of 317.5 million yuan ranks it among the top companies, with WuXi AppTec leading at 1 billion yuan, followed by China Resources Sanjiu and Baiyunshan at 751 million yuan and 650 million yuan, respectively [5].